139 related articles for article (PubMed ID: 19502596)
1. Urinary estrogen metabolites in women at high risk for breast cancer.
Im A; Vogel VG; Ahrendt G; Lloyd S; Ragin C; Garte S; Taioli E
Carcinogenesis; 2009 Sep; 30(9):1532-5. PubMed ID: 19502596
[TBL] [Abstract][Full Text] [Related]
2. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection.
Fowke JH; Qi D; Bradlow HL; Shu XO; Gao YT; Cheng JR; Jin F; Zheng W
Steroids; 2003 Jan; 68(1):65-72. PubMed ID: 12475724
[TBL] [Abstract][Full Text] [Related]
3. Urinary estrogen metabolites and breast cancer: a case-control study.
Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337
[TBL] [Abstract][Full Text] [Related]
4. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study.
Wellejus A; Olsen A; Tjonneland A; Thomsen BL; Overvad K; Loft S
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222
[TBL] [Abstract][Full Text] [Related]
5. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
Ho GH; Luo XW; Ji CY; Foo SC; Ng EH
Ann Acad Med Singap; 1998 Mar; 27(2):294-9. PubMed ID: 9663330
[TBL] [Abstract][Full Text] [Related]
6. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H
Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246
[TBL] [Abstract][Full Text] [Related]
7. The relation of urinary estrogen metabolites with mammographic densities in premenopausal women.
Maskarinec G; Heak S; Morimoto Y; Custer L; Franke AA
Cancer Epidemiol; 2012 Oct; 36(5):e310-6. PubMed ID: 22537763
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
[TBL] [Abstract][Full Text] [Related]
9. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
[TBL] [Abstract][Full Text] [Related]
10. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
[TBL] [Abstract][Full Text] [Related]
11. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.
Jernström H; Klug TL; Sepkovic DW; Bradlow HL; Narod SA
Carcinogenesis; 2003 May; 24(5):991-1005. PubMed ID: 12771045
[TBL] [Abstract][Full Text] [Related]
12. Urinary estrogen metabolites and their ratio among Asian American women.
Falk RT; Fears TR; Xu X; Hoover RN; Pike MC; Wu AH; Nomura AM; Kolonel LN; West DW; Sepkovic DW; Bradlow HL; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):221-6. PubMed ID: 15668498
[TBL] [Abstract][Full Text] [Related]
13. Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women?
Ursin G; Wilson M; Henderson BE; Kolonel LN; Monroe K; Lee HP; Seow A; Yu MC; Stanczyk FZ; Gentzschein E
Cancer Res; 2001 Apr; 61(8):3326-9. PubMed ID: 11309288
[TBL] [Abstract][Full Text] [Related]
14. Estrogen metabolism and breast cancer.
Kabat GC; O'Leary ES; Gammon MD; Sepkovic DW; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Bradlow HL
Epidemiology; 2006 Jan; 17(1):80-8. PubMed ID: 16357599
[TBL] [Abstract][Full Text] [Related]
15. Urinary markers of estrogen metabolism 2- and 16 alpha-hydroxylation in premenopausal women.
Pasagian-Macaulay A; Meilahn EN; Bradlow HL; Sepkovic DW; Buhari AM; Simkin-Silverman L; Wing RR; Kuller LH
Steroids; 1996 Aug; 61(8):461-7. PubMed ID: 8870165
[TBL] [Abstract][Full Text] [Related]
16. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
Alvarez-Vasquez RB; Axelrod D; Frenkel K; Newman MC; Sepkovic DW; Bradlow HL; Zumoff B
Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
[TBL] [Abstract][Full Text] [Related]
17. Re: Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
Castagnetta LA; Carruba G
J Natl Cancer Inst; 1999 Nov; 91(21):1893-4. PubMed ID: 10547401
[No Abstract] [Full Text] [Related]
18. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
[TBL] [Abstract][Full Text] [Related]
19. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
Ruan X; Seeger H; Wallwiener D; Huober J; Mueck AO
Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
[TBL] [Abstract][Full Text] [Related]
20. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women.
Fowke JH; Longcope C; Hebert JR
Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):773-9. PubMed ID: 10952093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
